S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
Are blue chip stocks a good investment?
All the trading advice you’ve ever received boils down to this (Ad)
Power Play: GE's game-changing technology for EVs and grids
Home sales hit a 13-year low... what now?
All the trading advice you’ve ever received boils down to this (Ad)
Stock market today: Wall Street takes a breather after best trading month of the year
A 15% gain in store for Five Below after rosy holiday outlook
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Elon Musk Gives Profanity-Laden Tirade During DealBook Interview: "Go F--- Yourself'
Salesforce, Big Lots rise; Pure Storage, Cracker Barrel fall, Thursday, 11/30/2023
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
Are blue chip stocks a good investment?
All the trading advice you’ve ever received boils down to this (Ad)
Power Play: GE's game-changing technology for EVs and grids
Home sales hit a 13-year low... what now?
All the trading advice you’ve ever received boils down to this (Ad)
Stock market today: Wall Street takes a breather after best trading month of the year
A 15% gain in store for Five Below after rosy holiday outlook
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Elon Musk Gives Profanity-Laden Tirade During DealBook Interview: "Go F--- Yourself'
Salesforce, Big Lots rise; Pure Storage, Cracker Barrel fall, Thursday, 11/30/2023
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
Are blue chip stocks a good investment?
All the trading advice you’ve ever received boils down to this (Ad)
Power Play: GE's game-changing technology for EVs and grids
Home sales hit a 13-year low... what now?
All the trading advice you’ve ever received boils down to this (Ad)
Stock market today: Wall Street takes a breather after best trading month of the year
A 15% gain in store for Five Below after rosy holiday outlook
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Elon Musk Gives Profanity-Laden Tirade During DealBook Interview: "Go F--- Yourself'
Salesforce, Big Lots rise; Pure Storage, Cracker Barrel fall, Thursday, 11/30/2023
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
Are blue chip stocks a good investment?
All the trading advice you’ve ever received boils down to this (Ad)
Power Play: GE's game-changing technology for EVs and grids
Home sales hit a 13-year low... what now?
All the trading advice you’ve ever received boils down to this (Ad)
Stock market today: Wall Street takes a breather after best trading month of the year
A 15% gain in store for Five Below after rosy holiday outlook
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Elon Musk Gives Profanity-Laden Tirade During DealBook Interview: "Go F--- Yourself'
Salesforce, Big Lots rise; Pure Storage, Cracker Barrel fall, Thursday, 11/30/2023

Vita Life Sciences Stock Price, News & Analysis (ASX:VLS)

Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2,815 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
3.48%
Price Target
N/A

About Vita Life Sciences

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, and Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritional products and nutritional oils; immunity; hair, skin, and nails; liver and digestion; weight management; cardiovascular health; pain and inflammation; men, women, and children's health; antioxidant; and bones and joints. The company markets its products through pharmacies and health food channels under the Herbs of Gold and VitaHealth brands. Vita Life Sciences Limited was founded in 1947 and is headquartered in Kirrawee, Australia.


VLS Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive VLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vita Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 10/5 Dividend
9/21/2023
Dividend Payable
10/05/2023
Today
11/30/2023

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$7.42 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$68.85 million
Book Value
A$0.70 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.40
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Andrew W. O'Keefe
    MD & Director
  • Mr. Chin Leng Khoo AGIA
    C.A., C.P.A., M.B.A., CFO, Company Secretary & Acting CEO of Asia Region
  • Ms. Melissa Pereira
    Group Marketing Manager (Leave of Absence)
  • Mr. Shaun Rutherford
    Chief Executive Officer of Herbs of Gold ANZ
  • Ms. June Lau
    General Manager of Operations & Business Support
  • Alexandra Ward
    Technical & NPD Manager














VLS Stock Analysis - Frequently Asked Questions

How often does Vita Life Sciences pay dividends? What is the dividend yield for Vita Life Sciences?

Vita Life Sciences declared a Interim dividend on Tuesday, September 19th. Investors of record on Thursday, October 5th will be paid a dividend of 0.03 per share on Thursday, October 5th. This represents a yield of 1.78%. The ex-dividend date of this dividend is Thursday, September 21st. This is a boost from the stock's previous Interim dividend of A$0.03.
Read our dividend analysis for VLS
.

Is Vita Life Sciences a good dividend stock?

Vita Life Sciences (ASX:VLS) pays an annual dividend of A$0.06 per share and currently has a dividend yield of 3.48%. The dividend payout ratio is 42.86%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for VLS.

This page (ASX:VLS) was last updated on 12/1/2023 by MarketBeat.com Staff

My Account -